After adding former Simpson Thacher & Bartlett antitrust attorney Andy Lacy last month in its Washington, DC, office, Goodwin Procter has continued to lean into the antitrust arena, adding another former Simpson Thacher attorney to its roster in Los Angeles.
Arman Oruc, who was at Simpson Thacher before becoming a founder, chief legal officer and board member at Biosplice Therapeutics, joined the Goodwin team on Wednesday, June 2, the firm announced.
Oruc has extensive experience advising on antitrust issues, including regulatory clearance of mergers and acquisitions across multiple jurisdictions, formulation of intellectual property strategies, standard-setting collaborations, and pricing and product design issues. He has acted as lead counsel in complex civil antitrust litigations, and has defended clients against criminal and civil investigations by the DOJ, FTC, European Commission and state regulators. After practicing for seventeen years as an antitrust lawyer and launching his prior law firm’s Washington, DC, office, Oruc was part of the founding team of Biosplice Therapeutics in 2013, where he also served as Chief Legal Officer and a member of the Board.
“I am excited to return to private practice as a partner at Goodwin, a firm recognized for being a leader in serving innovators and investors in complex transactions, including in the life sciences industry,” said Oruc. “I look forward to working with Goodwin’s global antitrust and M&A team to help clients navigate competition-related issues.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
